Chronobiology of Parkinson's disease : Past, present and future
Abstract Parkinson's disease is a neurodegenerative disorder predominately affecting midbrain dopaminergic neurons that results in a broad range of motor and non‐motor symptoms. Sleep complaints are among the most common non‐motor symptoms, even in the prodromal period. Sleep alterations in Parkinson's disease patients may be associated with dysregulation of circadian rhythms, intrinsic 24‐h cycles that control essential physiological functions, or with side effects from levodopa medication and physical and mental health challenges. The impact of circadian dysregulation on sleep disturbances in Parkinson's disease is not fully understood; as such, we review the systems, cellular and molecular mechanisms that may underlie circadian perturbations in Parkinson's disease. We also discuss the potential benefits of chronobiology‐based personalized medicine in the management of Parkinson's disease both in terms of behavioural and pharmacological interventions. We propose that a fuller understanding of circadian clock function may shed important new light on the aetiology and symptomatology of the disease and may allow for improvements in the quality of life for the millions of people with Parkinson's disease..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:57 |
|---|---|
| Enthalten in: |
European Journal of Neuroscience - 57(2023), 1, Seite 178-200 |
| Beteiligte Personen: |
Asadpoordezaki, Ziba [VerfasserIn] |
|---|
| Anmerkungen: |
© 2023 Federation of European Neuroscience Societies and John Wiley & Sons Ltd |
|---|
| Umfang: |
23 |
|---|
| doi: |
10.1111/ejn.15859 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
WLY005046297 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | WLY005046297 | ||
| 003 | DE-627 | ||
| 005 | 20231111151810.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230215s2023 xx |||||o 00| ||und c | ||
| 024 | 7 | |a 10.1111/ejn.15859 |2 doi | |
| 028 | 5 | 2 | |a 2023-11-11_EJN_2023_57_1.zip.xml |
| 035 | |a (DE-627)WLY005046297 | ||
| 035 | |a (WILEY)EJN15859 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 100 | 1 | |a Asadpoordezaki, Ziba |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Chronobiology of Parkinson's disease |b Past, present and future |
| 264 | 1 | |c 2023 | |
| 300 | |a 23 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © 2023 Federation of European Neuroscience Societies and John Wiley & Sons Ltd | ||
| 520 | |a Abstract Parkinson's disease is a neurodegenerative disorder predominately affecting midbrain dopaminergic neurons that results in a broad range of motor and non‐motor symptoms. Sleep complaints are among the most common non‐motor symptoms, even in the prodromal period. Sleep alterations in Parkinson's disease patients may be associated with dysregulation of circadian rhythms, intrinsic 24‐h cycles that control essential physiological functions, or with side effects from levodopa medication and physical and mental health challenges. The impact of circadian dysregulation on sleep disturbances in Parkinson's disease is not fully understood; as such, we review the systems, cellular and molecular mechanisms that may underlie circadian perturbations in Parkinson's disease. We also discuss the potential benefits of chronobiology‐based personalized medicine in the management of Parkinson's disease both in terms of behavioural and pharmacological interventions. We propose that a fuller understanding of circadian clock function may shed important new light on the aetiology and symptomatology of the disease and may allow for improvements in the quality of life for the millions of people with Parkinson's disease. | ||
| 700 | 1 | |a Coogan, Andrew N. |4 aut | |
| 700 | 1 | |a Henley, Beverley M. |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European Journal of Neuroscience |g 57(2023), 1, Seite 178-200 |w (DE-627)WLY005028965 |x 14609568 |7 nnns |
| 773 | 1 | 8 | |g volume:57 |g year:2023 |g number:1 |g pages:178-200 |g extent:23 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_WLY | ||
| 951 | |a AR | ||
| 952 | |d 57 |j 2023 |e 1 |h 178-200 |g 23 | ||